Datametrex AI Ltd V.DM

Alternate Symbol(s): DTMXF

Technology Information Technology Services

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, healthcare, and mobile gaming. It is focused on collecting, analyzing and presenting structured and unstructured data using machine learning and artificial intelligence. The Company's products include AnalyticsGPT, Cyber Security, and Healthcare. AnalyticsGPT platform scans vast data streams from social media, news, blogs, forums, messengers, enterprise data, and the dark Web, creating predictive analytics. Cyber Security is a deep analytics platform that captures, structures, and visualizes vast amounts of unstructured social media data, which is used as a discovery tool that allows organizations to make decisions. It offers Nexa Products, which consists of NexaSecurity and NexaSMART. Healthcare consists of Imagine Health Centres, a multidisciplinary healthcare facility, and Medi-Call, a telehealth platform. The Company also offers a mobile blockchain game, Cereal Crunch.

TSXV:DM - Post by User

Datametrex AI Ltd

<< Previous

Bullboard Posts

Next >>

Post by Long101on May 02, 2022 2:39pm

167 Views

Post# 34648459

Bids are building

The summary provided should get serious investors excited, but of course there are some who expected more and will complain. With bids building nicely, we're in for a bit of whipsaw ride today. Tomorrow will bring more clarity on the future of DM, but for now, the info looks pretty encouraging imo

In March of this year, the Company's wholly owned subsidiary, Nexalogy ("Nexalogy") successfully completed the first phase of its artificial intelligence contract with the Canadian government.
In November 2021, the Company received a P.O. for up to $1 million from an electric vehicle charging platform company and is looking forward to entering the electric vehicle space this year.
The Company officially moved into the telehealth vertical with the launch of its Medi-Call health app in April 2022 and has started taking its first orders. Medi-Call will be expanding to in-person visits in the upcoming months. The Company looks forward to expanding Medi-Call's geographic footprint this year.
The Company has seen an increase in demand for COVID-19 testing. This resulted in tremendous growth in testing within the film and production industry. In March alone, the Company conducted 25,333 COVID-19 tests and continues to build in this area.